Related references
Note: Only part of the references are listed.Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study
Paul D. Miller et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
E. Seeman
BONE (2007)
Osteoporosis prevention and therapy: preserving and building strength through bone quality
M. Kleerekoper
OSTEOPOROSIS INTERNATIONAL (2006)
Estrogen deficiency and bone loss: an inflammatory tale
MN Weitzmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society
Bruce Ettinger et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2006)
Bazedoxifene acetate: A selective estrogen receptor modulator with improved selectivity
BS Komm et al.
ENDOCRINOLOGY (2005)
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women
S Ronkin et al.
OBSTETRICS AND GYNECOLOGY (2005)
Safety and adverse effects associated with raloxifene: Multiple outcomes of raloxifene evaluation
D Grady et al.
OBSTETRICS AND GYNECOLOGY (2004)
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
NB Watts et al.
JOURNAL OF CLINICAL DENSITOMETRY (2004)
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
CH Chesnut et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
The revision of the Declaration of Helsinki: past, present and future
RV Carlson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate
R Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Sex steroids and the construction and conservation of the adult skeleton
BL Riggs et al.
ENDOCRINE REVIEWS (2002)
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
SR Cummings et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy
S Sarkar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Effect of risedronate on the risk of hip fracture in elderly women
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
SC Manolagas
ENDOCRINE REVIEWS (2000)
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
JY Reginster et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Risk of mortality following clinical fractures
JA Cauley et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Share Paper
